187 related articles for article (PubMed ID: 18515093)
1. Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells.
Sun J; Mustafi R; Cerda S; Chumsangsri A; Xia YR; Li YC; Bissonnette M
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):37-40. PubMed ID: 18515093
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells.
Yao B; He J; Yin X; Shi Y; Wan J; Tian Z
Toxicol Lett; 2019 Nov; 316():109-118. PubMed ID: 31472180
[TBL] [Abstract][Full Text] [Related]
3. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
4. Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum.
Ishizawa M; Akagi D; Makishima M
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986424
[TBL] [Abstract][Full Text] [Related]
5. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor.
Sun J; Kong J; Duan Y; Szeto FL; Liao A; Madara JL; Li YC
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E315-22. PubMed ID: 16507601
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts.
Szeto FL; Sun J; Kong J; Duan Y; Liao A; Madara JL; Li YC
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):563-6. PubMed ID: 17298882
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.
Adachi R; Honma Y; Masuno H; Kawana K; Shimomura I; Yamada S; Makishima M
J Lipid Res; 2005 Jan; 46(1):46-57. PubMed ID: 15489543
[TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
9. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia.
Ishizawa M; Matsunawa M; Adachi R; Uno S; Ikeda K; Masuno H; Shimizu M; Iwasaki K; Yamada S; Makishima M
J Lipid Res; 2008 Apr; 49(4):763-72. PubMed ID: 18180267
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
Teske KA; Bogart JW; Sanchez LM; Yu OB; Preston JV; Cook JM; Silvaggi NR; Bikle DD; Arnold LA
Eur J Med Chem; 2016 Feb; 109():238-46. PubMed ID: 26774929
[TBL] [Abstract][Full Text] [Related]
11. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives.
Masuno H; Ikura T; Morizono D; Orita I; Yamada S; Shimizu M; Ito N
J Lipid Res; 2013 Aug; 54(8):2206-2213. PubMed ID: 23723390
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor as an intestinal bile acid sensor.
Makishima M; Lu TT; Xie W; Whitfield GK; Domoto H; Evans RM; Haussler MR; Mangelsdorf DJ
Science; 2002 May; 296(5571):1313-6. PubMed ID: 12016314
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids.
Ikura T; Ito N
Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid can carry out in vivo functions of vitamin D.
Nehring JA; Zierold C; DeLuca HF
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10006-9. PubMed ID: 17535892
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals.
Adachi R; Shulman AI; Yamamoto K; Shimomura I; Yamada S; Mangelsdorf DJ; Makishima M
Mol Endocrinol; 2004 Jan; 18(1):43-52. PubMed ID: 14525957
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D Receptor Mediates Attenuating Effect of Lithocholic Acid on Dextran Sulfate Sodium Induced Colitis in Mice.
Kubota H; Ishizawa M; Kodama M; Nagase Y; Kato S; Makishima M; Sakurai K
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834927
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
Bao BY; Ting HJ; Hsu JW; Yasmin-Karim S; Messing E; Lee YF
J Steroid Biochem Mol Biol; 2010 May; 120(1):11-21. PubMed ID: 20206692
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function.
Farmer PK; He X; Schmitz ML; Rubin J; Nanes MS
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E213-20. PubMed ID: 10893342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
